













In April 2008 the In Vitro Meat Consortium held its first meeting at the Norwegian 
Food Research Institute. They are a group of scientists and advocates who seek to turn 
the techniques of tissue engineering to the production of food, producing meat in 
laboratories that has at no point been part of a living animal. This is a fascinating 
technology, and one that fits well with the topic of this SCRIPTed analysis section: 
the ‘zombification’ of meat products. I have been conducting interviews with 
scientists who are involved in In Vitro Meat research at the three main research sites 
to explore the emergent social, ethical and regulatory issues of the technology. In this 
discussion I first provide detail on the current level of scientific development in the 
field and then describe the social context and promise of In Vitro Meat, before finally 
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In April 2008 the In Vitro Meat Consortium held its first meeting at the Norwegian 
Food Research Institute. The Consortium identifies itself as “an international alliance 
of environmentally concerned scientists striving to facilitate the establishment of a 
large-scale process industry for the production of muscle tissue for human 
consumption through concerted R&D efforts and attraction of funding to fuel these 
efforts.”1. Essentially these scientists seek to turn the techniques of tissue engineering 
to the production of food; producing in laboratories meat that has at no point been part 
of a living animal. This is a fascinating technology, and, characterised as the 
‘zombification’ of meat products, one that fits well with the collection of analysis 
pieces in this SCRIPTed issue. While metaphors of zombies usually lead one to think 
of the ‘living-dead’, in vitro meat is perhaps best categorised as the ‘dead-living’, or 
perhaps the ‘living-never born’. 
The scientists involved in the in vitro meat project take a small amount of cells from a 
living animal and culture it in medium to encourage the cells to proliferate into lumps 
of muscle tissue which could, in principle, be eaten. This is distinct from cloned meat 
where an entire animal, using technology similar to that used to produce Dolly the 
Sheep, is cloned and then slaughtered. With in vitro meat, there is never a whole 
animal to slaughter. And because there has never been a whole animal we cannot say 
the tissue is the ‘living-dead’. This meat was never born, has never been ‘alive’ in any 
usual way we would apply to an animal, and has never been killed. 
These tissue engineering techniques were developed in biomedical research settings 
oriented towards curing disease. In the biomedical field, the promise of regenerative 
medicine is to transplant tissue into an unhealthy body to promote healthy cell growth 
in ill people. Stem cell use for such purposes has been subject to extensive legal, 
ethical and social science analysis,2 and sophisticated and expensive infrastructures 
have been established to regulate these technologies, allowing cells to be stored, 
multiplied and distributed internationally in ethically responsible ways.3 In vitro meat 
development is a form of stem cell science that, as with the regenerative medicine 
setting, looks to harness the growth potential of stem cells to grow quantities of 
healthy tissue. However while the technologies have much in common, the legal, 
ethical and social context of tissue engineering for food is very different to that of 
tissue engineering for biomedical purposes. In vitro meat has attracted inspection 
from broader academic disciplines, including ethicists,4 artists, 5 cultural studies, 6 
cultural theory, 7 and design.8 
                                                 
1 See the In Vitro Meat Consortium at http://invitromeat.org/index.php (accessed 9 July 2008). 
2 S Holm, “Going to the Roots of the Stem Cell Controversy” (2002) 16 Bioethics 493-507; A Webster 
and L Eriksson, “Governance-by-standards in the field of stem cells: managing uncertainty in the world 
of ‘basic innovation’” (2008) New Genetics and Society 27, 99-112; and S Parry, “Stem cell scientists’ 
discursive strategies for cognitive authority” (2009) 18 Science as Culture 89-114. 
3 N Stephens et al, “The UK Stem Cell Bank: Securing the past, validating the present, to protect the 
future” (2008) 17 Science as Culture 43-56. 
4 P Hopkins and A Dacey, “Vegetarian Meat: Could Technology Save Animals and Satisfy Meat 
Eaters?” (2008) 21 Journal of Agricultural Ethics 579-596. 
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The present work is an addition to these contributions. I am a sociologist and scholar 
of Science and Technology Studies with an interest in the regulatory and social 
framing of stem cell research. I have been conducting semi-structured interviews with 
scientists who have either been involved in, or have tried to be involved in, in vitro 
meat research. To date I have conducted eleven interviews during visits to the three 
main active sites: the Netherlands, Sweden and Norway. However, as I am still early 
in the data collection process, I remain cautious about any conclusions I develop in 
this article. Having said that, I will explore some of the social issues associated with 
this technology.  In the first section, I will provide further detail on making in vitro 
meat, in the second I will describe the social context and promise of in vitro meat, and 
in the final section I return to the central question of what exactly in vitro meat is, 
zombie or not. 
2. Making In Vitro Meat 
A technique for producing in vitro meat was patented in 1999,9 but Benjaminson, 
Gilchriest and Lorenz are usually credited with the first successful experiments, 
conducted in 2002.10 Their work was funded by NASA and explicitly addressed the 
feeding of astronauts in space, while considering the relationship between protein 
sources and space vehicle crew morale. The team successfully grew goldfish muscle 
cells, some of which were harvested for cooking, and - their paper could be read to 
suggest - eaten. While biologically the experiments met some success, NASA 
provided no further funding following their publication, and the research project 
ceased. Around the same time, Oron, Catts and Ionat Zurr – Harvard University tissue 
engineers – were bringing together laboratory work and art through in vitro meat 
technology,11 initially using pre-natal sheep cells to grow a piece of muscle tissue 
three centimetres in diameter. In 2003, their work became publicised when they 
                                                                                                                                            
5 I Zurr and O Catts, “Artistic life forms that would never survive Darwinian Evolution: Growing 
Semi-Living Entities” in: Art Association of Australia and New Zealand (ed), Art and Nature: 
Darwinism, Ecology, Biology and the Future of Art (2003); available at 
http://www.tca.uwa.edu.au/atGlance/pubMainFrames.html (accessed 3 September 2008). 
6 S McHugh, “‘Real Artificial Meat’ and the Future of Animal Agency”, unpublished, presented at the 
British Animal Studies Network meeting, London, 25 October 2008; L Kelley, “‘Tissue Culture, Meat 
and Art: Collaboration and Consumption In Vitro”, unpublished, presented at the Meet Animal Meat 
Symposium, Uppsala, 5 October 2009; L Kelley, “Arts Projects Acting as STS Research: Collaboration 
and Consumption In Vitro”, unpublished, presented at the Society for the Social Studies of Science 
Conference, Washington, 28-31 October 2009; and J Parry, “Oryx and Crake and the New Nostalgia 
for Meat” (2009) 17 Society and Animals 241-256. 
7 S Herbrechter, “Brooding – Life after Animals”, unpublished, presented at the Zoontotechnics 
(Animality/Technicity) Conference, Cardiff 12 May 2010. 
8 J King, Dressing the Meat of Tomorrow (2007), available at http://www.james-king.net/projects/meat 
(accessed 2 December 2008). 
9 See W van Eelen, W van Kooten and W Westerhof, “Industrial scale production of meat from in vitro 
cell cultures” (1999), Patent Description, available at 
http://l2.espacenet.com/espacenet/viewer?PN_WO9931222, as reported by P Edelman et al, “In Vitro-
Cultured Meat Production” (2005) 11 Tissue Engineering 659-622. 
10 M. Benjaminson, J Gilchriest and M Lorenz, “In vitro edible muscle protein production system 
(MPPS): Stage 1, Fish” (2002) 51 Acta Astronaut 879-89. 
11 I Zurr and O Catts, see note 5 above. 
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staged an art exhibition in Nantes, France: muscle tissue grown from frog cells was 
served to banquet guests in a gallery under public view. Apparently the dinner guests 
did not like the taste of the meat. 
These experiments were small scale preliminary investigations into the technical and 
social challenges of in vitro meat, and ongoing work today remains in these early 
stages. The main active research groups are located at universities in the Netherlands, 
Sweden and Norway. The Dutch group, which is the largest and most well funded of 
these, from 2005 to 2009 ran a project financed by SentreNovem – now part of  
Agentschap NL at the Dutch Ministry of Economic Affairs – comprising four  
PhD students, three full time staff and their line managers and  
supervisors.. The group is hopeful of a second phase of funding starting late 2010. 
The smaller projects in Sweden and Norway are funded largely through internal 
university funding, although external funding is frequently sought.  The Dutch group 
is looking to establish a pig derived cell line, meaning a population of cells that can be 
sustained indefinitely in controlled conditions, growing the cell numbers so they can 
continuously replace the existing stock and generate enough cells to be harvested for 
research or production use. Establishing cell lines of this sort in relation to mouse or 
human cells is common in biomedical research, but the shift to the use of pig tissue 
raises particular challenges. The Swedish group are using materials and surface 
science to understand how mouse muscle cells can be encouraged to bond to, and 
grow on, larger starch particles in specially configured bioreactors. The Norwegians 
are developing a focus on pig umbilical cord cells as a source of muscle tissue. All 
three groups run broader biomedical research programmes of which their In Vitro 
Meat work is a complementary element. 
There are also published accounts of how the field may develop further.12 The 
literature emphasises two different techniques, loosely referred to as ‘scaffold-based’ 
and ‘self-organising’ tissue culturing techniques. Each method has its own technical 
challenges and is suited to different outcomes. The scaffold based techniques are most 
suited to producing tissue akin to processed meats such as sausages and burgers that 
lack some of the textured complexity of highly structured meats like beef steaks or 
chicken breasts. The technique uses cells taken from an animal at either the 
embryonic stage (known as myoblasts) or the adult stage (known as skeletal muscle 
satellite cells) and attaches them to a scaffold made of protein meshwork. This is then 
spread over a culture medium and placed in a bioreactor resulting in myofiber tissue 
that can be cooked as meat. This ‘self organising’ technique requires a culture 
medium that directs tissue growth in the correctly organised form over three 
dimensions. In order to produce more complex meats scientists would need to emulate 
the in vivo structure of the tissues much more closely. This would require the 
production of tissue types beyond the muscle itself, including fat, blood vessels and 
connective tissue.  
                                                 
12 See P Edelman et al, see note 9 above; M Langelaan et al, “Meet the New Meat: Tissue Engineered 
Skeletal Muscle”’ (2009) Trends in Food Science & Technology; I Datar and M Betti, “Possibilities for 
an In Vitro Meat Production System” (2010) 11 Innovative Food Science and Emerging Technologies 
13–22. 
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The In Vitro Meat Consortium commissioned a UK biotechnology consultancy firm 
to compile an economic assessment and projection for the industry.13 It suggested that 
the meat might be marketable, given sufficient research and development investment. 
Initially it would remain a niche high-end market, priced just above free-range 
organic meats, targeting those motivated by its ethical, environmental and health 
promises and most likely in the form of pasta sauce or an equivalent. With subsequent 
development, advocates say, it could move into lower-end markets producing cheap 
meat for the masses. However there remain vast technical challenges to the successful 
production of in vitro meat. Cell culturing limits need to be explored, scaffolds need 
to be flexible and edible, and growth mediums need to contain the nutritional 
components missing due to the absence of a digestive system. These issues affect the 
production of even the smallest quantity of meat. There are many more barriers to 
producing in vitro meat in the quantities and at the cost needed to make it suitable for 
commercial consumption. 
3. The Promissory Languages and Social Space of In Vitro Meat Research 
In vitro meat protagonists make a range of claims for the product. The development of 
meat free from the practical issues of livestock rearing is said to make it suitable for 
vegetarians and vegans, as no animals have been harmed or killed in its production. 
The absence of actual animals in the production process also deems the food 
environmentally friendly because it negates the contribution of livestock rearing to 
global warming and de-forestation. Furthermore, its supporters claim, the production 
process will appeal to health advocates because the level of control over it ensures 
that the meat can be rendered free of fat, naturally occurring animal disease, and 
medical interventions such as vaccination and steroid use experienced by whole 
animal meat sources. We have already noted that one very different type of potential 
market is found in space and defence agencies. In situations of long distance space 
travel or lengthy periods of seclusion, for example in a nuclear bunker, the ability to 
produce meat with no access to farming facilities would be useful. Scientists are keen 
to promote these promissory languages as a mechanism for enrolling support and 
funds to the research. These pro-in vitro meat claims can however be contested, and 
the extent to which the identified potential markets will resist these configurations of 
their politics and identities is yet to be determined. 
There is a further, different, pro-in vitro meat voice. These are individuals and 
campaign groups who see potential in the technology for social good, usually as a 
means to cut green house gas emissions or reduce animal cruelty. The leading 
campaign group is called New Harvest. They focus entirely on promoting and raising 
funds for in vitro meat development. While essentially spearheaded by one individual, 
New Harvest is well connected to scientists active in the area, and has had moderate 
success in raising and distributing financial support to the field. In addition to 
targeting laboratory work, New Harvest recently funded Dutch and UK based 
researchers to conduct an environmental analysis of the energy requirements for in 
vitro meat production. The goal was to provide estimates of the potential benefit of in 
                                                 
13 Exmoor Pharma Concepts, The In Vitro Meat Consortium Preliminary Economics Study Project 
29071 V5 March 2008 (2008), available at 
http://invitromeat.org/images/Papers/invitro%20meat%20economics%20study%20v5%20%20march%
2008.pdf (accessed 8 August 2008). 
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vitro meat, in terms of green house gas omissions, as compared to whole animal meat 
production methods. The group is well organised, with a well-produced website 
containing sufficient information to be used as a resource by the scientists active in 
the field, as well wider publics.14 Since its inception in 2004, New Harvest has 
featured consistently in the media reporting on in vitro meat.  
Another high profile, although less consistently pursued, intervention supporting in 
vitro meat was made by People for the Ethical Treatment of Animals (PETA), who, in 
2008, announced a prize of US$1m for the first group to commercialise in vitro meat 
in the United States.15 PETA framed in vitro meat as an animal rights issue in keeping 
with its broader portfolio of high impact campaign tactics. The competition was 
reported to have caused ‘near civil war’ within the organisation over whether it, a pro-
vegan organisation, should be supporting meat production at all (Schwartz 2008).16 
While the political alignment of animal rights activists and innovative biotechnology 
could be an example of the ‘strange bedfellows’ that categorically re-defining 
bioscience can provoke (Evans, Plows, & Welsh 2007), it is also easy to be cynical 
about the genuine nature of competition. The Contest Rules set a high benchmark for 
winning the prize: selling 2,000lbs of meat in no less than 10 states consecutively for 
three months at the same price as whole animal meat before mid-2012.17 Such a high 
level of production looks unrealistic. Furthermore, as some scientists have expressed, 
if PETA was serious about supporting the research it would have awarded the $1m as 
research grants to develop the technology instead of as a prize for completing the 
work. That said, the PETA intervention was important for significantly raising the 
profile of the technology (as well as its own profile) and making many people 
consider, perhaps for the first time, whether they would eat it, zombie or not. 
4. In Vitro Meat: Zombies or More? 
It would be quite reasonable if you, the reader, were still asking yourself, ‘So what 
actually is in vitro meat?’ Or maybe your question is, ‘Would I eat in vitro meat?’, or 
perhaps, ‘Would I feed it to my family?’ Others may be asking, ‘'Do I believe this is 
good for the environment/for my health/for animal welfare?’, and the more attuned to 
the theme of this section in this issue of the journal will surely be asking, ‘So is in 
vitro meat really the living-dead, the dead-living, or the living-never born’? These are  
pertinent questions, but unfortunately not ones I can answer in this  
paper. 
The laboratory production of animal tissue for human consumption challenges our 
existing norms and boundaries around food, nature and kinship. This is to the extent 
that what In Vitro Meat actually is, or will be, remains undefined and contestable. 
Such uncertainty has been documented in other biological and technical domains in 
                                                 
14 See New Harvest at http://www.new-harvest.org/default.php (accessed 17 June 2010). 
15 PETA, “PETA Offers $1 Million Reward to First to Make In Vitro Meat” (2008), at 
http://www.peta.org/feat_in_vitro_contest.asp (accessed 17 June 2010). 
16 J Schwartz, “PETA’s Latest Tactic: $1 Million for Fake Meat” (2008) New York Times. 
17 PETA, ‘In Vitro Meat Production—Contest Rules’ (2008), at 
http://www.peta.org/feat_in_vitro_contest.asp (accessed 17 June 2010). 
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terms of the linearity of life,18 and species boundaries.19 But in the case of in vitro 
meat, there is the extra challenge of bringing meaning to techniques that, having been 
developed in the biomedical field to benefit human health, are now being applied to 
food production. 
The technology raises for scientists, regulators and consumers many questions to 
which there are no clear answers: Will in vitro meat cultured from chicken cells be 
chicken? If so, will it be chicken in the same way as a chicken breast from whole-
animal farming methods is chicken, or in some other way? What formulation of 
provenance and kinship allows all three: a whole chicken, a chicken breast, and an in 
vitro chicken breast, all to be chicken? Furthermore, what politics does the in vitro 
chicken breast embody? Is it environmentally sound or a threat to our natural 
ecology? Is it a humane treatment of animals or a denial of their integrity? Will in 
vitro meat even be food, or a Frankensteinian scientific misadventure? At the moment 
we simply don’t know. 
So, as provoked by the themes of this special issue, does the idea of the zombie help 
us to understand in vitro meat? Certainly at least one thinker believes it does. Stephan 
Herbrechter, taking his lead from Lauro and Embry‘s 2008 Zombie Manifesto,20 has 
used the term ‘Zombie Meat’ in questioning what the emergence of in vitro meat 
could mean in relation to a broader erosion of the human-animal boundary and the 
emergence of a different form of ‘biopolitics’.21 My own work focuses less on what 
new technologies could mean or imply and more on documenting the ambiguities as 
they operate today. And in that spirit I would prefer not to say that in vitro meat is 
‘Zombie Meat’, or even that it is ‘meat’ at all. Equally, I do not want to say that in 
vitro meat is not meat. Instead, I would argue that we are still at a point at which the 
definition or categorisation of in vitro meat – what it is - remains unclear. The best 
description of in vitro meat is an ‘as-yet undefined ontological object’. Shared 
narratives and political identities of this tissue have yet to emerge, and the forms these 
may take are both unknowable and contested. At present it simply has no common 
ontological meaning. 
I remain open to the possibilities for the future. It is entirely plausible that, with 
adequate funding, in vitro meat could find a route to commercialisation and human 
diets. It is equally possible that the technology could be wholly rejected by the 
consuming public, or might never move beyond the current stage of basic laboratory 
research. The insight is to acknowledge the interpretative flexibility of the small 
lumps of tissue that have been produced in laboratories, and recognise the 
significance of competing narratives that try to bring function and meaning to them. 
Such narratives seek to establish socio-technical alignments between the material, the 
political, the commercial and the edible, in a formation that facilitates success of the 
field, however that may be defined. The robustness of these alignments remains to be 
                                                 
18 N Brown and A Webster, New Medical Technologies and Society: Reordering Life (Cambridge: 
Polity Press, 2004). 
19 D Haraway, When Species Meet (Minneapolis: University of Minnesota Press, 2008). 
20 See SJ Lauro and K Embry, “A Zombie Manifesto: The Nonhuman Condition in the Era of 
Advanced Capitalism” (2008) 35 Boundary 2, 85-108. 
21 S Herbrechter, see note 7 above. 
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seen, but it is clear that, should the technology develop and further enter the public 
imagination, this robustness will be tested. 
5. Conclusion 
The title of this paper is a question: ‘In Vitro Meat: Zombies on the Menu?’ To 
conclude, I offer an answer in two parts. Firstly, is in vitro meat zombie? Well, we do 
not know, and each reader can decide for themselves whether the tissue whether the 
tissue is the ‘living-dead’, the ‘dead-living’, or the ‘living-never born’. Secondly, is in 
vitro meat on the menu? Here I feel more assured in saying that, with the science still 
in the early stages, it is unlikely that the tissue will be commercially available anytime 
soon. As Banjaminson et al22 and Zurr and Catts23 demonstrate however, it has been 
on the menu at least twice, and maybe one day it will be on the menu again.  
 
                                                 
22 M Benjaminson, J Gilchriest and M Lorenz, see note 10 above. 
23 I Zurr and O Catts, see note 5 above. 
